共 50 条
- [25] Safety, tolerability, QTc evaluation, and pharmacokinetics of single and multiple doses of enzastaurin HCl (LY317615), a protein kinase C-β inhibitor, in healthy subjects JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1138 - 1151
- [27] Enzastaurin (LY317615.HCI) suppresses signaling through the PKC and AKT pathways, inducing apoptosis, suppressing tumor-induced angiogenesis and reducing growth of human cancer xenografts EJC SUPPLEMENTS, 2006, 4 (12): : 176 - 176